Why Women Are Misdiagnosed: The History of Medical Misogyny
Medicine is widely regarded as an objective, evidence-based discipline. Its authority rests on the assumption that clinical decisions are guided by data, observation, and scientific reasoning. However, the development of modern medicine did not occur in a social vacuum. It evolved within historical contexts that systematically excluded women, not only from positions of power, but from the data that continues to inform diagnosis today.
Gender bias in healthcare continues to influence how women are diagnosed. Many women experience diagnostic delay, symptom dismissal, or misdiagnosis. Not because their conditions are rare, but because the system they are assessed within was not designed around their physiology or lived experience.
Understanding the history of medical misogyny is therefore essential. It provides critical context for why women are misdiagnosed, and why these patterns persist in modern clinical practice.
Historical Foundations: Pathologising the Female Body
The conceptualisation of women’s health in early Western medicine was deeply shaped by the diagnosis of “hysteria,” a term derived from the Greek hystera, meaning uterus. This diagnosis was used for centuries to categorise a wide range of physical and psychological symptoms that lacked clear explanation within the medical knowledge of the time.
Rather than prompting further physiological investigation, such symptoms were frequently attributed to inherent instability within the female body or psyche. Women’s reports of pain, fatigue, or neurological disturbance were interpreted as manifestations of emotional or moral weakness, rather than legitimate medical concerns.
While hysteria has been formally abandoned as a diagnosis, its underlying logic “the tendency to psychologise women’s symptoms when they are not immediately understood” has proven more durable. Contemporary research suggests that this pattern persists in modern clinical encounters, particularly in cases involving chronic pain or medically unexplained symptoms.
The Androcentric Bias in Medical Research
A more subtle, yet equally significant, form of medical misogyny emerged in the structure of clinical research itself. Throughout much of the twentieth century, women were routinely excluded from medical trials. Concerns regarding hormonal variability and potential risks to pregnancy led to a preference for male participants, whose physiology was considered more stable and therefore easier to study.
The consequence of this exclusion is that the “standard patient” in medical research has historically been male. Diagnostic criteria, treatment protocols, and symptom profiles have been disproportionately derived from male data and subsequently generalised to the broader population.
This is a systemic data gap. When women are not adequately represented in datasets, their experiences are rendered statistically invisible. This invisibility is not neutral. It directly shapes clinical knowledge, influencing what is recognised, what is considered typical, and ultimately, what is diagnosed.
Diagnostic Delay and the Persistence of Bias
The persistence of gender bias in diagnosis is not solely attributable to historical exclusion from research. It is also reinforced by broader social norms that shape perceptions of credibility, pain, and emotional expression.
Research demonstrates that women’s pain is more likely to be underestimated or attributed to psychological factors. This contributes directly to diagnostic delay, in which symptoms are minimised, investigations are deferred, and appropriate referrals are postponed.
In Australia, a significant proportion of women report experiencing bias or discrimination within healthcare settings. These experiences are not isolated incidents, but reflect systemic patterns consistent with international findings.
Diagnostic delay, therefore, should not be understood purely as a function of disease complexity. It is also a predictable outcome of structural and cognitive bias within healthcare systems.
When Symptoms Do Not Fit: The Clinical Consequence
Many conditions that disproportionately affect women, including endometriosis, autoimmune diseases, and chronic pain disorders, are associated with prolonged diagnostic timelines.
These conditions often present with symptoms that are:
variable over time
difficult to measure objectively
or spread across multiple systems
Within existing diagnostic frameworks, such presentations are frequently labelled as “non-specific.” While clinically convenient, this classification reflects the limitations of current models rather than the absence of disease.
Over time, this creates a recognisable pattern:
Symptoms → dismissal → delayed investigation → delayed diagnosis
This is the lived experience behind the data.
Reframing the Problem: From Individual Cases to Systemic Patterns
Medical misogyny rarely presents as overt discrimination. It is more often expressed through small, cumulative effects: slightly longer delays, slightly lower perceived credibility, slightly less aggressive investigation.
Individually, these differences may appear minor. Collectively, they contribute to significant disparities in diagnostic outcomes.
Recognising this pattern allows for a reframing of patient experience. When women are misdiagnosed or dismissed, it is often interpreted as an isolated issue. However, the historical and structural context suggests that these experiences are, in many cases, predictable.
Implications for Diagnosis Today
Understanding the historical context of gender bias in healthcare provides a clearer framework for navigating modern diagnosis.
When symptoms are complex, variable, or do not align with standard diagnostic models, they require translation into a format that can be recognised within clinical systems. This typically involves:
clear timelines
consistent symptom patterns
specific, concrete examples
When information is structured in this way, it becomes easier to map onto clinical reasoning processes. Patterns are more visible. Gaps are easier to identify. Dismissal becomes more difficult to justify.
The history of medical misogyny is not confined to outdated diagnoses or obsolete theories. It remains embedded in the data, structures, and assumptions that shape modern healthcare.
Its effects are visible in patterns of misdiagnosis, diagnostic delay, and symptom dismissal experienced by women across a wide range of conditions.
Recognising these patterns does not diminish the value of medicine. It strengthens our ability to use it effectively.
Because when the limitations of a system are understood, they can be navigated with greater precision.
References
Criado Perez, C. (2019). Invisible Women: Data Bias in a World Designed for Men. Abrams Press.
Merone, L., Tsey, K., Russell, D., & Nagle, C. (2022). Sex inequalities in medical research: A systematic scoping review.
Samulowitz, A., Gremyr, I., Eriksson, E., & Hensing, G. (2018). “Brave men” and “emotional women”: A theory-guided literature review on gender bias in healthcare and gendered norms towards patients with chronic pain. Pain Research and Management.
Royal Australian College of General Practitioners. (2021). Gender bias in medicine and medical research is still putting women at risk.
Australian Government Department of Health. (2024). 2 out of 3 women experience discrimination in healthcare.
